Intracrine signaling is a mode of hormone and growth factor action in which signaling molecules exert their effects within the same cell that produces them, without being secreted into the extracellular environment. The term intracrine was originally coined to describe peptides that either act within the cell that synthesized them or function after being internalized by their target cells.[1] While this model was initially developed through studies on the intracellular action of angiotensin II, it has since been recognized as a fundamental mechanism applicable to numerous peptide hormones and growth factors.
Unlike classical endocrine, autocrine, and paracrine signaling, where signaling molecules leave the cell and interact with membrane-bound receptors, intracrine signaling functions exclusively within the intracellular environment, often targeting nuclear or cytoplasmic receptors.[2] This mechanism allows cells to autonomously regulate essential biological functions, including gene expression, differentiation, and survival. One of the most well-characterized examples of intracrine signaling is the local synthesis and action of sex steroids within immune cells, which modulate inflammatory responses and metabolic pathways.[3]
The intracrine hypothesis has been instrumental in predicting novel functions for peptide hormones and has generated significant insights with potential therapeutic implications. Since its initial proposal, an expanding body of observational evidence—independent of the hypothesis itself—has reinforced the role of intracrine signaling in various physiological and pathological processes, including immune regulation, metabolic control, and cancer progression.
© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search